NCT01288859

Brief Summary

Polyphenolic compounds exert several health benefits depending on bioavailability. Encapsulation may improve bioavailability of these compounds.This study will evaluate bioavailability of some polyphenols (curcumin and cocoa polyphenols) from new enriched-foods. In particular bread and nut based creams will be used as food matrices to include free or encapsulated polyphenols.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Dec 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 27, 2011

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 3, 2011

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

August 1, 2012

Completed
Last Updated

August 1, 2012

Status Verified

July 1, 2012

Enrollment Period

2 months

First QC Date

January 27, 2011

Results QC Date

July 25, 2011

Last Update Submit

July 31, 2012

Conditions

Keywords

polyphenolscurcuminbioavailabilitycocoa

Outcome Measures

Primary Outcomes (3)

  • Serum Polyphenol Concentrations Over 24h From Food Consumption

    Area Under the Curves (AUC) from 0 to 24h of parent polyphenols was calculated using a trapezoidal rule applied to the concentration-time curves of compounds.

    0, 0.5, 1, 2, 4, 6, and 24 hours post-dose

  • Urinary Excretion of Total Polyphenols

    Area Under the Curve (AUC) from 0 to 24h of total polyphenols (sum of parent polyphenols and metabolites)was calculated using a trapezoidal rule applied to the urinary concentration-time curves of compounds.

    Time intervals: 0-2, 2-4, 4-6, 6-8, 10-24 hours post-dose.

  • Amount of Total Fecal Polyphenols

    Amount of parent polyphenols and metabolites in feces was calculated by multiplying net concentrations by the amount of feces.

    0 and 24 hours post-dose.

Study Arms (6)

encapsulated curcumin

EXPERIMENTAL
Other: encapsulated curcumin

encapsulated curcumin + PQG

EXPERIMENTAL

PQG means Piperine, Quercetin and Genistein

Other: encapsulated curcumin + PQG

free cocoa polyphenol

ACTIVE COMPARATOR
Other: free cocoa polyphenol

control

PLACEBO COMPARATOR
Other: control nut cream

encapsulated cocoa polyphenols

EXPERIMENTAL
Other: encapsulated cocoa polyphenols

free curcumin

ACTIVE COMPARATOR

Subjects will consume bread added with free curcumin

Other: free curcumin

Interventions

free curcumin in bread, dosage 1g/100g, 200g/day per 1 day

free curcumin

encapsulated curcumin-enriched bread, 1g/100g bread, 200g bread/day

encapsulated curcumin

bread enriched with encapsulated curcumin plus piperine, quercetin and genistein, 1g/100g bread, 200g bread/day

encapsulated curcumin + PQG

nut cream enriched with free cocoa polyphenols, 1,5 g/100g cream, 100g/day per 1 day

free cocoa polyphenol

nut cream enriched with encapsulated cocoa polyphenols, 1,5 g/100g cream, 100g/day per 1 day

encapsulated cocoa polyphenols

nut cream, cocoa polyphenols 0g/100g cream, 100 g/day per 1 day

control

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old, male and female
  • Healthy by medical assessment
  • Normal weight: BMI 18 - 25
  • Sign of a written informed consent

You may not qualify if:

  • Age \> 18 and \< 45 years old
  • Pregnancy or breastfeeding
  • Intestinal or metabolic diseases/disorders such as diabetic, renal, hepatic, hypertension, pancreatic or ulcer, including lactose-intolerance
  • Previous abdominal/gastrointestinal surgery
  • Regular consumption of medication
  • Antibiotic therapy within 2 months previous the study
  • Food allergies and intolerances (celiac disease, lactose intolerance, nut allergy etc)
  • Unwilling to consume experimental foods
  • Concurrent participation or having participated to another clinical trial during the last 3 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Food Science

Portici, 80055, Italy

Location

Results Point of Contact

Title
Prof. Vincenzo Fogliano
Organization
University of Naples

Study Officials

  • Vincenzo Fogliano, Professor

    University of Naples

    PRINCIPAL INVESTIGATOR
  • Paola Vitaglione, Researcher

    University of Naples

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 27, 2011

First Posted

February 3, 2011

Study Start

December 1, 2010

Primary Completion

February 1, 2011

Study Completion

July 1, 2011

Last Updated

August 1, 2012

Results First Posted

August 1, 2012

Record last verified: 2012-07

Locations